Request for Sample Report@ https://www.alliedmarketresearch.com/request-sample/1677
According to a new report published by Allied Market Research, the
global proteomics market was valued at $21.12 Bn in 2019 and is projected to
reach $49.97 Bn by 2027 at a CAGR of 12.2% from 2020 to 2027.
Major drivers of the proteomics market include rise in popularity
of personalized medicine, increase in research and development expenditure and
technological advancements related to proteomics components. Furthermore, high
costs associated with proteomics components and lack of skilled professionals
hamper the market growth.
The protein microarray segment in the proteomics instruments
market accounted for the highest revenue in 2019 owing to the high adoption of
this technology to track protein interactions in a shorter period of time
compared to other technologies. Moreover, this method is labor-intensive and
cost-effective. With the help of protein arrays, comprehensive information on
DNA/RNA binding proteins can be provided.
North America accounted for the largest share of the proteomics
market in 2019 with nearly 39.0% of the total market due to the growing
popularity and adoption of personalized medicine and favorable government
funding and initiatives to develop new therapies. However, Asia-Pacific is
expected to grow at a CAGR of 15.6% during the period 2019 to 2027, as the prevalence
of chronic diseases increases and researchers' interest in using proteomics in
disease diagnosis and treatment increases.
Key Findings:
·
Reagents segment generated the highest revenue
in 2019 and is projected to grow at a CAGR of 11.7% during the forecast period.
·
The instruments segment is forecast to grow at
the highest CAGR throughout the period.
·
Drug discovery dominated the global proteomics
applications market in 2019, accounting for nearly 60.0% of the proteomics
market size in 2019.
·
In 2019, the US was the leading country,
occupying the largest proteomics market share in North America.
The key companies profiled in the
proteomics market report include Agilent Technologies Inc., Danaher
Corporation, LI-COR, Inc., PerkinElmer, Inc., Thermo Fisher Scientific, Inc.,
HORIBA, Ltd., Bio-Rad Laboratories, Inc., Bruker Corporation, General Electric
(GE), and Waters Corporation. The other players included in the value chain
analysis (but not included in the report) are Becton, Dickinson and Company,
Caprion Biosciences, and others.
0 Comments